SARS‐CoV‐2 may decrease the cell surface expression of ACE2 and thereby decrease a lung‐protective mechanism, resulting in greater inflammation, edema, and more severe ARDS. The gene discussed is ACE2; the disease is acute respiratory distress syndrome.